Vengoji, Raghupathy
Atri, Pranita
Macha, Muzafar A.
Seshacharyulu, Parthasarathy
Perumal, Naveenkumar
Mallya, Kavita
Liu, Yutong
Smith, Lynette M.
Rachagani, Satyanarayana
Mahapatra, Sidharth
Ponnusamy, Moorthy P.
Jain, Maneesh
Batra, Surinder K.
Shonka, Nicole
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (P01 CA217798, R01 CA210637, R01 CA183459, R01 CA195586, R01 CA228524, U01 CA200466)
Article History
Received: 14 April 2021
Accepted: 8 October 2021
First Online: 25 October 2021
Declarations
:
: All animal experiments were carried out in accordance with U.S. Public Health Service, “Guidelines for the care and use of laboratory animals”, in accordance to ARRIVE guidelines and with approval of the UNMC Institutional Animal Care and Use Committee (IACUC) (UNMC IACUC # 20–028-04 FC; IACUC # 16–108-11-FC).
: Not applicable.
: SKB is a co-founder of Sanguine Diagnostics and Therapeutics, Inc. The other authors disclosed no potential conflicts of interest.